Table 1.
Studies | Study Type | Study Sample Specie |
Models/Methods | Dose | Route | Duration | Results | Mechanism |
---|---|---|---|---|---|---|---|---|
Guney 2008 [58] |
Animal in vivo |
rats | Endometrium fragments sutured to the abdominal wall | 10 mg/kg daily | ip | 4 weeks | Decreased lesion sizes and weight | Increased SOD, CAT Decreased MDA, COX-2 |
Paul 2008 [59] |
Animal in vivo |
mice | Intraperitoneal transplantation | 48 mg/kg daily | ip | 10 or 20 days | / | Increased TIMP-1 Decreased MMP-9 |
Paul 2010 [60] |
Animal in vivo |
mice | Intraperitoneal transplantation | 48 mg/kg daily | ip | 10 or 20 days | / | Increased TIMP-3 Decreased MMP3 |
Yildirim 2010 [61] |
Animal in vivo |
rats | Endometrium fragments sutured to the abdominal wall | 10 mg/kg daily | ip | 2 weeks | Decreased lesion sizes Decreased histopathologic scores |
Increased SOD, CAT |
Koc 2010 [62] |
Animal in vivo |
rats | Endometrium fragments sutured to the abdominal wall | 10 mg/kg daily | ip | 4 weeks | Decreased histopathologic score | Increased SOD, CAT Decreased MDA |
Kocadal 2013 [63] |
Animal in vivo |
rats | Intraperitoneal transplantation | 20 mg/kg daily | im and ip | 2 weeks | Decreased lesion sizes Decreased histopathologic score |
/ |
Yilmaz 2015 [51] |
Animal in vivo |
rats | Endometrium fragments sutured to the abdominal wall | 10 mg/kg daily | ip | 4 weeks | Decreased lesion weight Decreased histopathologic scores |
Increased SOD, MDA, TIMP-2 Decreased VEGF, MMP-9 |
Cetinkaya 2015 [50] |
Animal in vivo |
rats | Endometrium fragments sutured to the abdominal wall | 10 or 20 mg/kg daily | im and ip | 2 weeks | Decreased lesion sizes in both treatment groups without significant difference | / |
Shasha 2018 [64] |
Cell in vitro |
human | Endometriotic eutopic epithelial cell culture | 1 mM | culture medium | 72 h | / | Increased Numb, E-cadherin Decreased migration, invasion and Notch1, Vimentin, Slug, Snail |
ip, Intraperitoneal injection; im, Intramuscular injection; SOD, Superoxide dismutase; CAT, Catalase; MDA, Malondialdehyde; COX-2, Cyclooxygenase 2; TIMP, Tissue inhibitors of metalloprotease; MMP, Matrix metalloproteinase; VEGF, Vascular endothelial growth factor.